Go back

'Mad Money w/ Jim Cramer 9/8/26

44m 28s

'Mad Money w/ Jim Cramer 9/8/26

Kramer argues that the market is being overly dominated by data center narratives, leading investors to miss significant opportunities in other sectors. He urges diversification, pointing to strong growth stories such as GE Aerospace’s $12 billion acquisition of a precision castings company, Hinge Health’s rapid expansion in telemedicine, and Enbridge’s resilient pipeline business. He also highlights consumer trends like Robinhood’s young, growing user base and Max Levien’s buy-now-pay-later model. While acknowledging data centers remain important, Kramer believes overexposure to them is risky. He recommends selling some data center holdings to reduce vulnerability during market downturns and instead allocating capital to resilient, high-growth, or defensive sectors. This approach ensures investors benefit from a broader range of market dynamics. He also ties this strategy to his fantasy stock football analogy, emphasizing balance, risk management, and diversification—core principles for building a resilient portfolio. Ultimately, Kramer believes the market needs consolidation and more strategic deals, not just data center hype, and calls for disciplined, diversified investing to thrive amid volatility.

Transcription

8391 Words, 46305 Characters

English
My mission is simple, to make you money. I'm here to level the playing field for all investors. There's always a more market somewhere, and I promise to help you find it. Man, money starts now. Hey, I'm Kramer. Welcome to Man, Money. Welcome to Kramer. Let's be my friends. I'm just trying to save a little bit of money here. My job is to just entertain, but then you get to some teaching. Call me 1-800-743-CMU-C. Tweet me at you, Kramer. There's more to life, and investing, than the data center. I get it. The money's huge. It's incredibly exciting. Hardly a day goes by without something big happening. A new model of open AI. It's been on a terror revival of intel. It could be gigantic. I like the philosophical debate about the machines becoming our overlords. However, the endless focus on the data center and the anti-data center backlash is obscuring opportunity after opportunity away from it. And I am no longer willing to tolerate you missing needs. And that's why, after a day with the Dow Sank 628 points. The SB7.5% has to climb 3.2%. I want to talk to you about some of the other terrific stories that people are indeed missing out on, because of data center obsession. No, I'm not saying that I've lost faith in the data center story. Not at all. I'm quite sanguine about it. And I think the group will start roaring again after the election. I'm not abandoning stocks for my child. So it's like Geneva Nova, which makes the turbines, they call them turbines, they turn natural gas and electricity, or intel, which makes CPUs and is raising prices on them, because there's so much more demand than there is supply. We just bought a micron for the child's trust. It's really small. Of course, in Boise, Idaho, I'm going to give a CMBC investing talk Thursday noon, which starts with why I actually sold corning. You certainly don't want to miss that explanation. So I still believe in the data center, but I also want to open your eyes to other opportunities. This morning, for example, GE Aerospace spent nearly $12 billion to buy a castings company, called Consolidated Precision Products, to integrate this key segment into its supply chain. It's vital for both commercial aircraft and gently defense, both of which are booming. Now, on a day where oil's up, you might not want to focus on anything airline related, but travel's been booming the whole time. The whole time the aeratomers are going on. This acquisition will pay off quickly for GE making it more likely that they can accelerate production. This is also good news, therefore, for Boeing, a huge customer of GE that needs to boost its production speed, GE is relatively close to its highs, deservedly so. Boeing nowhere near its high. Yet the order book is full. Let's think there was this negative article about how Boeing's being hurt by the problem-filled spirit aerosystems acquisition made that one two years ago. But that actually hadn't been done, because Boeing, like GE Aerospace, needs to get better control of its supply chain. Ah, how you say? Who needs that kind of problem? Boeing just reported its slowest leverage in four months. I come back and say, wait a second. First, the problems from the spirit deal are now behind them. You know what? The story is actually old news. Plus, CEO Kelly Ortberg has made it clear that orders would be lumpy. I knew that. And look, I know the high price of oil, prickly jet fuel, is bad news for the airlines. But the higher price of fuel also makes these new engines and airplanes far more valuable than before. Why? The way more energy efficient. It's a good situation that has nothing to do with the data center. It does require more better tech that AI can help with. Next, have you noticed the incredible run in Robinhood? The stock? I know what that a lot has happened here is related to the recent strength and crypto. Any excitement of the prediction markets. But that's facing a big picture. Robinhood owns the youth market. Three-quarters of its clientele are under 45 years old. The median age is 35. Their deposits are growing at a 28% clip. Those are staggering figures, as is their 28.4 million funded customers. Or how about the buy now pay later a business that's a firm? Max Levsion's company has 28 million active customers. A firm is a -- it's kind of who is who a partisan, including the biggest Amazon Costco, as well as Shopify, Target, and Apple, which launches a pricey new phone tomorrow. We just saw their quarter. It was excellent. People are selling a firm because they fear a rate height from the Fed. I get that. But people would be paying substantially more for the stock without that worry. What matters is that the quarter had so much momentum that I think you'll see great numbers right through the end of the year. Holiday season. At the same time, Mr. Schmidt is health care companies in bull market mode. Chief among them is a company called Hinge Health, which is a digital physical therapy company. More on that one later, you get the benefit of your employer pays the bill. Here's what it's about. Metronite. Metronite, the medical device, come to be shocked with a big upside surprise and a major increase in organic growth. It's separating its worries and the diabetes division. By the end of the year, I don't want to be in a diabetes division in a world where GOP-1s are sending it. The stock is now where it was when it reported. Yet it is a vastly improved year-over-year business. To me, that is just crazy. As long as the war with the Randrax one, it's easy to recommend the refiners like a Valero or a marathon. I don't see it any any time soon. Not with the US and the Rand trading follies this evening at islands and ships in the strait. But how about a pipeline that moves about 30% of all crude produce in North America? Now I'm talking about Enbridge, which has a 5.5% yield. It also has a natural gas. You know, it transports 20% of the natural gas. It's consumed in America. Okay, it's Canadian. But it's not quite up in the tariff fight, because slapping tariffs on Canadian energy would be economic suicide for our country. When I wrote "How to Make Money in Any Market" and send you, by the way, a free sign book if you join the investing club. Now, I didn't know that enterprise product partners was going to be this. maybe the single biggest pipeline winner in this country. Thanks to the war. I didn't see that more coming. The CEO of Enterprise Jim Teague has raised awareness for the company's profit opportunity because of the Hormuz closing. The margins of some of the slickness like ethane to ethylene, ethylene to polyethylene and have soared. As Teague says, the Euston Ship Channel is now just as important as the straight of Hormuz. Now, there's an endorsement. Stock yields 5.8%. Finally, there's an Amchen. Admittedly, this one takes a little bit of 42 days. It was down 44 points today. The stock is declining because it has a drug candidate that's similar to a Novartis product which failed a cardiovascular trial today, sending a stock down $22. Novartis had high hopes for the drug testing for its heart attack and for stroke. We won't get a read out on Amchen's similar pipeline drug until 2027 or 2028. And it's slightly different. But with this decline, Amchen could remove that drug from its portfolio and the stock probably wouldn't go down all that much more. Now, I'm not saying that every one of these ideas is better than anything data center related. I'm saying that the endless focus on the data center, coupled with the incredible backlash against them, is going to make it for rough sledding between now and the election. We can't have our heads in this sand. But if you diversify away from many things data center, not all, many, I think the next two months will be a happier, more lucrative time for you. Here's the bottom line. If we were playing a mitaversified tonight, I think you hear me recommend selling quite a few data center stories right in the strength to make sure that you can't be taken down by the anti-data center and groundswell that most people in Wall Street are trying to ignore. It's just not worth it to load up the boat. Better to have a few, then look elsewhere for the many other opportunities that are right in front of you. How about we go to Spencer and Alabama Spencer? Jimmy Chiu, how are you? Spencer, I am doing well. How about you, Chief? Doing great, man. I'm calling in regards to an AI stock that I would 200 shares up. I could see it being a big player in the AI boom, with 60 billion backlog in the August goes profit and pretty much feels incredibly undervalued. The stock is SMCI, Jimmy. Okay, so SMCI, to me, has some irregularities that are related to accounting. I cannot recommend it. I see the momentum, absolutely. But you know what? I've been saying by Dell, and I think Dell's better than Super Micro, and I am sticking by that. I think it's quite even after this big run. It's still very, very attractive. There's a lot of opportunity this morning. Just have to look a little bit harder. And maybe how about this outside pure data center themes? Oh man, what are you doing tonight? It's time for our annual fantasy football stock draft. Stay tuned for which games I think are going to be the big winners this season. We just mentioned what. Then Marbelle Sank on Ernie's part. Our investors looking past this company's potential. I've got the CEO. And we saw some deal news in the market today. But I think we're due for some more consolidation. That is, if you want to stay afloat. I'll explain why. So stay with Kramer. Don't miss a second of Mad Money. Follow @Jim Kramer on X. Have a question. Tweet Kramer. #MadMensions. Send Jim an email to [email protected]. Or give us a call at 1-800-743-CNBC. Miss something? Head to madmoney.cnbc.com. We just had our first real weekend of college football. And the new NFL season kickoff was tomorrow. A rematch of the Super Bowl, the defending championship in Seattle, Seox, against the New England Patriots. That also means it's time for the new fantasy football season for the Mad Money staff. our trade for the not-year average slumped dickletting. I'm a little despondent about throwing the 8th pick, but I'm trying to stay positive. If you're interested, I'm going to post my final roster for the Steve Addy's team on X tonight. Oh, and slumped dick is the neatest term that has nothing to do whatsoever with football, but a previous commissioner picked about 15 years ago and we've been stuck with it. And every time a new season rolls around, I like to play fantasy stock football here on man money, because picking a fantasy team has a lot in common with putting together a diversified stock portfolio. Hey, by the way, are the 11 stocks that picked last year? They're up 31% on average, trouncing the 18% gain in this be 500 of the same period. That was easy. We know how to draft on man money. So break out your pen and paper and let's get started. Now, we got a storm of our quarter back in fantasy. Good boy, you're typically only playing one quarterback per week. And what you want here is consistent production. That's why for the past several years, I've picked Apple as my fantasy stock football, QB. As always, I only don't trade it. Not only does Apple make the most beloved products in the world, they're playing a very different game from their mega cap peers. Everybody else is spending hundreds of billions of dollars on AI. Apple spending next to nothing, just party with AI companies, they desperately want access to Apple's massive user base. To me, that makes Apple a lot less risky than the other members of the Magnificent Seven. To put that in NFL terms, Apple reminds me of Josh Allen, the quarterback for the Buffalo Bills. Allen's a known quantity. He was the league MVP two years ago. Then last year, he had 25 passing touchdowns, 14 rushing touchdowns. Well, it gives you more points in fantasy football. But the main parallel is that both Apple and Allen are now under new management. For the first time in 15 years, Apple has a new CEO, John Ternis, who officially took over from Tim Koch last week. Similarly, at the end of last season, the Buffalo Bills let go of former head coach, Sean McDermott, nine seasons. But only former offensive coordinator, Joe Brady, to the position. Next, let's talk running backs, keep position in fantasy, which one are the equivalent of competitors. Stocks, you can just think grow and grow and grow over time. Basically, you want to run back like Nvidia. The other stock on my own, it don't trade at least. Now, in the past, I've called Nvidia a wide receiver for your portfolio, more of a rapid growth name. But at this point, it's mature enough to be a running back. That said, Nvidia is still on track to put up 70% revenue growth. Next year, don't worry about today's action. It was just crazy down. For the NFL analog, I like probably the best player in the game, Jamir Gibbs, the thrilling running back for the Detroit Lions, who can stack up yards and touchdowns both by running the ball and catching basses. He's the complete back. It's just like Nvidia's advanced computing platforms, which combine chips, networking equipment and software. Both Gibbs and Nvidia are known for their speed. But overall, this is a comparison all about quality. Just as Nvidia should be one of the first stocks someone buys when starting to build a portfolio, Gibbs is going to be one of the first few players taking any fantasy draft. Put it this way. I have the eighth pick in my league draft and there's no way I'm going to be able to get Gibbs. I'm lucky if I get Cam Scatabo. Beyond that, I've got a couple more running backs. He's become a great compounder. Thanks to this Booming G.O.P. dash 1, weight loss business. For NFL comparison, we're going to have to stay in Indianapolis. We're in Lily's base and give you Colts running back Jonathan Taylor, entering a seven season with more than 7,500 career rushing yards already under his spell. Taylor isn't going to catch anyone by surprise anymore, like Lily. But you can probably get Taylor with a mid to late first round pick. Just like you can now buy Lily, it's just over 30 times earnings. That's down from 45 times earnings at the beginning of the year. Both rappers and decent value. For my third running back, let's bring in some new blood, please. I'm bringing in Medline, the largest IPO of 2025. This is a distributor of medical surgical products in the United. It sounds like back and things and growing business, selling its home medical places, consumables came publicly as December. After a hot start, it's cooled off significantly. Pulling back from a high of 50 in February to the mid 30s now, only slightly above where it came public. But for those who have patience, I think Medline could be a long-term compounder. It's a real sleeper. Hey, NFL analog, how about the Arizona Cardinals' rookie running back Jeremiah Love? The third overall pick in April's NFL draft. But beyond both being new, I think the analogy holds because both Medline and Love have temporary question marks. Medline's well off its highs. In part, thanks to a warehouse fire in June. Love is a great track record in Notre Dame, but now he's got an ankle injury. I think these are temporary issues for both. Sometimes it's best to go off the beaten path. Adam Schefter would love Medline. How about some wide receivers? In terms of your stock portfolio, wide receivers are the equivalent of pure growth stocks. They could explode for huge point outputs in any given week. If they have a bunch of catches and scored a few long touchdowns, but they're a lot more hitter missed than a running bat, what does it sound like? Palantir. That's why Palantir Technology is a software company with a stock that was white hot in late 2004, and most of 2025 before getting ice cold for the first half of this year. And only recently turned hot again, rallying with it's 60% from shooting lows, not bad. When it's working though, there have been few stocks better than Palantir. They reached an important magnificent quarter, but the stock also sells from more than 100 times this year's early assessments, not cheap. Best NFL analog for Palantir, well there I like Jim R. Chase from the Cincinnati Bengals. One of the best receivers in the league, even as he's coming off a down a year last season, Chase also has some injury concerns, making him more risky like Palantir's high-priced earnings multiple. Next for a less whiskey-wide receiver, how about Amazon? Their Amazon Web Services business is on fire. The stock's gotten pretty cheaper. It's trading at 20 times this year's earnings estimates, not many times they're remembering it at that low. We're going to stay in Seattle for the Amazon analog, C.O.X receiver, Jackson Smith-Najigma, who had a breakout season last year and earned NFL offensive player of the year. He might not have the app absolute upside, but I think he's more dependable in other top-played options. Call Amazon a "sleep at night" bro stock. JSN offers the same thing for your fantasy team. I love that kid. Finally, I like Dell Technologies for a wide receiver spot, riding a wave of insatiable demand for his AI services. That's why the stock's more than quadrupled for the year. The NFL equivalent, look, I'd say CD-LAM, the Cowboys' wide receiver, feels under-appreciated this year. Just like Dell was entering 2026. Lamb's got a great track record, but last year the Cowboys picked up George Pickens, and he did it better. So people are sleeping on Lamb coming into this season. I think he's ready to reassure himself. Just like Dell's been reassuring himself in tech, he can't double-team. Dell, here's the bottom line. For this year's fantasy stock football draft, I've given you a quarterback. Three running backs, three wide receivers, stick around after the break for the rest of the draft. Meh money is back after the break. Coming up, you can't have a full team without great role players. So Kramer's rounding out his fantasy stock roster, next. For the break we kicked off our annual fantasy stock football special wide drift, a portfolio of stocks. Same way, I'd be drafting my fantasy team for the Sloan particularly later tonight. They're two great tastes. Taste great together. Just as you need different kinds of players to balance out your team, you need different kinds of stocks to diversify your portfolio. That's why I love doing this exercise. So far I can be a quarterback, three wide receivers and three running backs. Those are the core of your team. Now let's fill out the roster with the rest of the positions. First key to tight end, this is a hybrid offensive position on some place to tight end. Actually I don't think it'll fit the line. Charge only with blocky. One other place to tight end is in the singles from a wide receiver. They're out running routes, catching passes, scoring touchdowns. For the tight end equivalent of our fantasy stock football portfolio, I'm going to pick a new one here. Hinge health, a relatively new medical technology company that came public last year. After quite first year of trading, it's had a major breakout and more than tripling from its February lows. Yet it still remains an under the radar sleeper. Hinge health is effectively telemedicine for a musculoskeletal issues. Employers and managed care companies pay for their services for their employees and members because it's much cheaper than traditional physical therapy and much more convenient for patients. It's part healthcare, part technology. Hinge health is going to track to put up nearly 50% revenue growth this year but it's not a growth of any cost operation. The company's profitable. It still sells for 40 times earnings even after the stocks tripled since February. Okay, so who's the NFL analog for Hinge health? Yeah, I'm thinking Indianapolis Colts tight end Tyler Warren for this one. First of all, they're both second year players Hinge is a class from 2025 by P.O. name that meets the exploded hire. Warren's a Penn State product was a rookie last year, put up some solid numbers over 800 yards, four touchdowns, but I'm hoping he can break out in the second NFL season just like Hinge did. Next, the final offensive spot on the roster is typically the flex position. This is a concept that's unique to fantasy football. The flex spot can be filled with a running back, a wide receiver or a tight end. Basically just one points from that player. As many as you can't anyway you can't. For me, I want to play SpaceX for the flex spot. This new IPO is the stock that we won't grow from no matter how we edit. The flex term even feels appropriate for SpaceX doesn't it? I mean, because this is a company that's hard to put in one box. They're oldest and most advanced divisions. Rockets. The ones for hire business. They're most lucrative division at least for now is the Starling satellite internet business. But if you're a long term bull, then you're probably most interested and excited about the company's AI business. At the end of the day though, the shareholders just want to see the stock put some points in the board. Anyway, again, although I acknowledge this one's might take a little longer to pay off, especially given that a bunch of restricted SpaceX stock is unlocking as early as tomorrow. So who's the SpaceX equipped on the NFLWAM, being real charitable here? I think it's Atlanta Falcons running back B. John Robinson making the most sense. Like SpaceX, Robinson's multifaceted, additionally 1500 yards rushing, seven rushing touchdowns last year, he had over eight out of yards receiving and four touchdown catches hard to bring down. He's even dabble a bit in acting with a minor, well, a couple minor roles. One, Netflix is out of banks and some Disney Channel show. Robinson is truly a jackable trades. Of course, both SpaceX and Robinson are expensive in their own way. SpaceX is expensive because the company's currently losing money and the stock's trading at basically 50 times this year's earnings estimates. I'm sorry, sales estimates. Robinson is expensive because he'll probably cost you a top five pick in your fantasy trade. But both are about as exciting as it gets in their respective fields. Beyond the offense, there's a spot on your roster for something called a defense/special team's pick in fantasy football. And for the most part, what you want from your fantasy football defense is very straightforward. You want them to give up as few points as possible, but defense in fantasy is a bit different because you can also get upside from sacks, turnovers, and especially defense and special teams touchdats. So for our stock market equivalent, I think that Merck's a good fit. As a drug company, Merck's inherently defensive in nature does fine even a bad economy. Good, if the fed chooses to jack up rates, right? At the same time, it can also give you real upside. As we saw when Merck's partner, Mo Durna, put up some promising melanoma vaccine results. There's a reason Merck's now up 41% year to date. In terms of the NFL, that reminds me of the LA Rams defense. The only concern is age. The Rams have to do well this year because it's a ticking clock for them, given that the team has so many older players. Merck, too, is racing against the clock to build a pipeline of new drugs that can offset some big upcoming patent expressions from their fantastic key true to oncology platform. Finally, we have to round out what our fantasy roster with a kicker. In fantasy football, kicker can get negative points if they miss extra points or field goals. So you really got to have some of the accuracy, but you can also get a nice bundle of points for a long field goal, so a kicker with range is a nice bonus. As I see it, a kicker is kind of like, it's like a good energy stop. It's like Chevron. It usually doesn't trade with the rest of the market because the higher oil is bad for everybody else in business. Plus, it's got an excellent 3.4% yield, that's like a steady flow of extra point kicks. But as we've seen, there are times like this year where oil prices are rising and Chevron can give you great returns. So far this year, this stock is up really 40%. That's a season when your kicker hits a couple of 60 plus yard field goals and earns you a surprise winner to. A couple years ago, Chevron officially moved his corporate headquarters from California to Houston, Texas. So we think a good and a full analog is used in Texans kicker, Kimmy Fairburn. He's the second bet of Kimey Fairburn. It's the hardest thing to spell the whole thing. The second best kicker in fantasy football issue, Fairburn was perfect with this extra point kicks last season and went 44 for 48 on field goals with the four misses all coming from over 50 yards. Pretty reasonable. You won't catch me visiting for a kicker in tonight's 3F on far too disciplined for that. But if I did, Fairburn is one of the few kickers who might be worth it the bottom one. That's a wrap for our annual fantasy stock football draft. Now it's time for me to buckle down because the not-your-average Slobodiga starts in about an hour and a half and our draft, well let's just say I got to get to work building my own championship team and I've won a couple of times. Let's go to Dan in Pennsylvania, Dan. Jim, how are you? Thank you for taking my call. Long time, listen to first-time caller. Oh, great, Dan. Thank you. What's going on? Uh, my question is, Lulu and I met. Uh, is there any chance for that company to come back? I know they have a low PAD. They have a new CEO coming in. It seems to me as though they have lost their way and is it a whole buy or sell? I think that this year, whatever's going on at that company, it's just abysmal whether it be the board, whether it be the execution, whether it be the way that the message. I don't like it. I don't like it even right here because it's still, it's still got a whole lot of points that it can fall. I think that it's, you know, look, it's a 10 times earnings but I don't think it's going to make those earnings. So, uh, at 103, no, I'm going to stay, say, maybe, I don't know, 85, it's a, it, it, it's, I don't want to say it's a bad company but it is executing really good. All right, just like you always need a well-rounded fantasy football team, you need a well-rounded portfolio. Hopefully you'll get your stocks in this clinical way. You can evaluate your position. That's what I want. In diversification, of course. Watch where we have money at. Including my exclusive with Mark Vell. Dan, this market is in need of one big thing and without it, everything is at risk. And while we pull back some of our positions for the Cabot Trust, and all your calls, of course, wrapping fire tonight's edition of The Lightning Round. So stay with great. Okay, what that just happened to the stock of Mark Vell when it reported a week and a half ago. This semiconductor company with a major data center explosion reported a healthy beat raise. Yet, the stock plunge more than 10% that it stays. I'm silly. Why did it get hit so hard? Some of that's because the expectations were extremely high since the stock's been on fire. Some of it's because we got more color on Mark Vell's collaboration with Google. They're making chips to rival and videos. But it turns out to be years before they really start boosting the numbers. Still, the company's making fortunes versus what we thought it could at that long ago. Well, today we spoke with Matt Murphy. He's the chairman's CEO of Mark Vell and get a better sense of what's happening here. Take a look. All right, so Matt, welcome to New York. This has been a remarkable time for the company. I've never seen these many great things happen at your company right now. Yeah, thanks Jim. I mean, it's been a lot of change this year in the positive sense. I mean, when I was on your show in December, I think in some ways I was on the defense and you asked me some very pointed questions about competition and things like that. Because all that was overblown completely and-- And these were press comments that said that you were going to lose certain contracts that were just untrue, frankly. Right. Exactly. So we move past that. And actually, I was looking back at that time we were guiding this year to be 10 billion in revenue and next year, 2027 at 13 and a half. We're now at 12 for this year and 18 for next year. So we've gone from 23 and a half billion last December over the two-year period to 30. And we're just in September right now. So that's up like almost 30% in that time frame. So clearly things have gone well. We announced a huge partnership with Invidia, which Jim and I came on your show to talk about. Including a stake. Including an equity investment and then also recently a partnership with a warna agreement with Google. So a lot of good stuff's been happening. The numbers have been great. Companies firing and all cylinders. All right. Well, we're going to go into this, but first, everyone's excited about October 6th, which is your media. I'm excited about October 6th meeting you gave five years ago, where you told me what could happen. And you told me that almost no one believed you. It turned out to be much bigger than even you thought, didn't it? Right. It did. I mean, I'll give you kind of two data points. Five years ago, we had our last full-blown investor day and we talked about a growth rate for like a three-year period of 15 to 20% per year, with operating margins in the 38 to 40% range, that type of thing. It's five years later. If you look at the 12 billion, we would have grown over 20% a year compounded for the last five years. We said we'd hit the operating margin target range in Q4. So we did what we said. Two years ago, we did a very specific AI investor event in New York. And at that time, things had gotten better. We had talked about doing 15 billion in data center revenue in 2028 off a $2 billion base from 2023. Okay. We're at right now, if you look at the 18 billion total Marvel for next year, over 15 billion of that's going to be from data center. So basically, we've come in a full year and taken the company from 2 billion in change in data center revenue in 2023 to 15, 16 billion next year. So it's gone very well. It's been fantastic. It was a big ramp. It was a big ramp. No, it's been a big ramp. The big ramp. But let's talk about the one that may be, and I've discussed with you offline, when someone says you're the next trillion dollar company and you're a company, and the dollar that's in $219, what do you do? And I'm talking about Jensomone, anointing you, because it had to be a surprise and holy cow. You can argue it's a target on your back where you can say, I'm going to live up to that man. Where are we? Right. Yeah. So at Computex in June, I gave a keynote presentation. My first one, and Jensomone was one of the guest speakers I had, and we were talking at that time about how in the AI cycle, we've had the Compute Wave, right, which was all the GPU XPU companies. That was a huge ramp two, three years ago. It's still going. Then we had the memory cycle. And then what I was talking about was the connectivity wave, right, which is now all the connectivity required to connect all the memory and the Compute together. And then Jensom came on stage, and I think backed up that vision, and certainly we had a high hopes for the company. Look, I would say this, we're driving the company to levels that I probably couldn't have imagined 10 years when I became CEO, but the future's very exciting and Investor asked me the same thing recently, hey, how do you get from here to there, which is say four times the valuation increase, roughly four or five times? And I said, look, when I became CEO in 2016, our valuation, our market cap is almost 40x since that time. So look, we got another four to go, and it's not easy, and I think there's an aspirational number out there for sure. We're just focused on driving the business, creating the value for the shareholders along the way, and I'm very excited about this October 6th to give our kind of new five-year marker, four to five-year marker of where we can go. - Yeah, and I'm going to take it. I know I'm going to believe you, and then we'll be listening to it previously now, when Google comes in, Alphabet, and they're, they want basically 59 million, you could argue, Marvell shares, roughly seven percent of the company. Don't you say to yourself, guys, look, you don't need to do this. We're thrilled just doing the business. Obviously, they want a partnership very, very badly. You could have just taken a contract. - Right, yeah, I mean, so if you back up, so we have a longstanding history with them. I think if you look at the economics and what was put on the table, and you look at the total value of the warrant, which is 120 billion total cumulative revenue to go get the six and a half percent, we felt that that trade was well worth it. I mean, what it really says at a high level is we have customers that want to partner with us, and they want to be part of our success. And I think some of it, Frank, who's had known you for a very long time, they do want to be part of your success. You've been straight forward, you've come out of nowhere. You've done an amazing job. They want to partner with Matt Murphy. - Well, I think so. I think they want to partner. I'll tell you this, in this market, these large, hyper-scale customers and the ecosystem around it, it's really based on trust in the end. Can you trust the engineering team and the company's going to deliver the chip? Can you trust the management team that they're going to shoot you straight? Can you trust that the capacity and the supply is going to be there, and can you trust the CEO at the end of the day that's going to do right by you? And I think we spent 10 years building the business here. This is no fly-by-night, new thing that we just got into. We called out this data infrastructure opportunity. In 2016 is the next big wave, okay? And so I've been building this company from a very different point of view from 10 years ago into one that's focused on that market. And I think trust has been a huge part of it in our brand and our credibility. - Now, is trust a tougher with Amazon, which you have an amazing relationship? When they turn around, they do a deal with Qualcomm that arguably could have gone to you or because your stock is up, maybe I'm making the wrong judgment. Maybe that's a separate kind of business. - Yeah, well, I'd say this. I think it's a competitive market and kind of per my earlier comment, AI's now become the market to be in. - Yes. - But this is the market we identified 10 years ago. So we've been quietly and slowly and now more publicly 'cause we've gotten bigger, building that business up. We have meaningful relationships with all the big four hyperscalers. We actually do custom silicon gym for all four. On optical connectivity, we are the market category leader. We effectively invented the category with INFI, which is a great company that we merged with. - Nice acquisition. - And acquired in 2021, that team has done phenomenal. And that connectivity supplies across the entire ecosystem. So we're very confident in our position in how we've evolved in this market across all the US hyperscalers and the entire ecosystem. - Well, we should also talk about, I mean, I was shocked. You were gave a terrific intro to whip 210 in 2022 for the noise award. So it's not just optic, and it's not just AI. You have tremendous relationships, even same with Intel. - Absolutely. We are basically the Switzerland to this entire market right now. We work with everybody. And I think the fact that we are agnostic to the XPU or the GPU. And because we're the leader in optical connectivity, which is effectively a merchant product, it sells across all of the different customers and the different types of connectivity. So we have the broadest product line with the highest performance. And that's very valuable to these customers. - Well, look, I want to congratulate you on your success, including coming on here when the stock was pretty low or having bought a lot of stock and just faced the music and said basically, yes, you're the signal, the rest was noise. Those who believed you'd quite a triple. Those who didn't, I have nothing to say to them. - Hey, a bunch of us, myself, my CFO and my two group presidents, we all bought stock in the mid-70s. - Well, people should look for that. We're trying to find a stock. Look for a conviction. Matt Murphy, Maribel Chairman and CEO. Congratulations. And we'll look forward to October 6th. - Thank you. - Thank you. - Yeah, mine's back. - Coming up, he's the fastest mind on Wall Street. So we're putting him to the test with your help. Bring on the lightning round. - Next. (upbeat music) - Quick reminder. This limited time Labor Day opportunity to join CMEC Investing Club in soon. And of course, what do you get? You had a signed copy of my latest book, "How to Make Money in Any Market." So here's what you gotta do. You gotta open your phone. You gotta scan the QR code or write this one down. Visit cmbc.com/cramerclub. cmbc.com/cramerclub. And do it today, please. Limited time only. And now it is time. (audience laughing) - It's time for the lightning round. (audience laughing) - We're about to talk to Bob and myself. So I'm doing a real close-in. My step first is going to play the sound. (buzzer) And then the lightning round is over. Are you ready? Skeeing down. It's a lightning round. It's about to start with Darren and California Darren. - Hey, how you doing, Jim? - I'm doing good. - Boo-yah, what's going on? - Hey, I wanted to know about the Joby Aviation. - Okay, I've been against Joby 'cause it's losing all out of money and I'm gonna stick with that position. It's an interesting spec, but I would not put my money in it. Let's go to Sam and Massachusetts Sam. - Jim, let's come with all the shortage in munitions. I've been looking at the steel industry specifically R.F. To talk it out before the S&P. And I think it's pretty good to do well as many-- - You're right! - R.O.S. is terrific! I prefer New Corp, but you're absolutely right to bring me R.S. It's a very, very good company. Now we're gonna go to Tony and Florida, Tony. - Hey, Jim, I want to thank you. I'm a club member since they won and everything's been great. - Thank you, buddy. Thank you very much. - I want to ask you about the company that owns a bunch of malls 'cause we go there every weekend. We're gonna T.J. Max, we're gonna go home good. It's the Simon Foppini's group. Should I buy one? Oh my God, Simon Foppini's four and a quarter percent yield. It is so great to give you two. I also like Federal Realty, both of them are excellent. Let's go to Federal Realty as shopping centers. Let's go to Bob in Ohio, Bob. - Hey, good evening, Jim, and thank you for taking my call. - Of course, thank you. - My question's about a company that operates in Southeast Asia and is a hybrid of both the Uber and DoorDash business models. They also have a growing fintech banking segment embedded in the business. Grab holdings have 3.4 billion in revenue last year and a net profit of 200 million. - Okay, well, I'm gonna interrupt you. I have never liked grab holdings. I have said that I did not think it was a situation that is worth our investing time. It is now down to three. I think it's a $3 spec. Remember Stocks do stop at zero. Let's go to Bill and Texas Bill. - Oh yeah, Jim. - Boy out, Bill. - You're the man. - Oh, thank you so much. - Thank you. - Thank you so much for all your wisdom and expertise. - Thank you. - Thank you, Bill. - Thank you. - What was wondering if after a pretty significant pullback would now be a good time to take a look at turn of the industry's TREM? - Yes, yes. Real car shouldn't be down this much. I like your thinking. You waited for the big hit. Now to the good place, I would pull the trigger. Let's go to Spencer, now I'll ban a Spencer. - I love the things that have been happening in the medical community, especially with the advancements of breast cancer and COPD with AstraZeneca, what's a long-term play? - Right now, AstraZeneca reminds me of Cummings, not unlike the Vartus. I'm a little nervous about it. It's been missing some of its trials. I don't think the COPD is enough to change my mind, by the way. I do think the COPD has once we've really been in COPD. I am not going to put my money on AstraZeneca. And that, ladies and gentlemen, the conclusion of the Lightning round. The Lightning round is sponsored by Charles Schwab. Coming up, there's one thing Kramer thinks this market desperately needs ASAP. He's explaining what it is. Next. - Oh, yeah, again, Kramer. I'm a first time caller. A happy 12 member. I want to thank you for being the peak champion of the best. Thank you for helping me become a millionaire. This market needs some consolidation and we need it fast. I want more deals like we got today when GE Aerospace bought consolidated precision products for $11.75 billion in part to boost its defense business. GE bought this from a pair of private equity firms. Of course, it would be better if we got some acquisitions of publicly trading companies because there's just too much stock for sale out there. Right now, the most salient part of the tape is the ongoing rollout of SpaceX. They've been unlocking their shares gradually and Neutron comes off restriction tomorrow. 319 million shares are 7% of the shares that are subject to the early lock up period. Currently, only 1.7 billion shares are 14% of the company is now free to trade. There seems to be an endless amount of supply that stays at the markets. So far, there's been far less supply than feared though. That's because while the stock's up nicely from the IPO, it's not up enough to trigger on additional lock up expressions that could have happened. Plus, people seem to have a lot of faith in Elon Musk, don't they? So they're sitting on their shares. Even if they don't have to. But over the next year, we're looking at massive amounts of stock coming off the sidelines here. Meanwhile, the underwriters are teaming up an IPO for Aura. That's that smart ring maker. It's a deal that can value the company at $16 billion. I've seen that SB Energy deal back by soft banks for power and data centers is in the hopper $5 billion all free possibly, as well as a small deal for Aura. Yeah, that's consumer products, Jim, might come public this fall, be a KKR deal. But lurking is anthropic, and perhaps more important anthropics, numbers. If it's solid problem, the kind of revenue growth we've heard about, it could be a gigantic IPO. And investors will sell all sorts of other stocks in order to raise money to participate. Right on top of that, there's OpenAI, which just put out a new model called Astra. That seems to rival anthropic, most powerful offerings. By this time in the year, you'd usually expect some takeovers that would free up some cash though, to allow managers to partake in these coming deals. Probably all vying to be the largest ever. We were supposed to be in the golden year and version that, was this is, why aren't we applying regulators? So far, a little show for question is why. First, just because the federal regulators are on board, that doesn't mean the states are. 12 states of Attorney General are soon to block that paramount Warner Brothers deal. It's not clear what would appease them. But they're holding up an 81 billion dollar transaction, not including debt. Second, Wall Street isn't exactly invapping these deals up. When we learned that Solstice advanced materials was buying element solutions for 14.5 billion dollars in cash and stock recently, the deal fell apart. shareholders hated it. Solstice saw it stuck crushed. Seven weeks later, they canceled the merger, stocks came running, but the sad stock came running back. Finally, the feds have shown no sign that they're eager to block bank deals, where there could be hundreds of mergers to consolidate, very unsolicited industry. They quickly bust the biggest deal, Santa and Derrick's $12.3 billion purchase of Webster. That's a terrific bank. They call it a stand for 95 Bares of Connecticut, 76 in New York, and 18 in Massachusetts. This deal could increase competition in these areas, but more important is the beginning of a new wave of bank mergers. So far that hasn't happened. Of course, look, this year hasn't been a bust for M&A. It's well ahead of last year, more than $1.1 trillion of transactions. But many of the biggest deals have yet to close, including next year or a dominion and Fox woku. More important, I'm not hearing anything new in the works right now. None of this would matter if interest rates were as low as they used to be. But when you get a 5.2% return for 30 year piece of paper, so much more is free, that represents serious competition in the stock market. And with the next data center equity deal, always just a few feet away, I don't know about you. I'm growing weary of all this new stock. It's something you need to watch, because as I always say, nothing stops a bull, like too much new stock supply, and not enough spare cash to handle it. Like I said, there's always a bull market, so I promise I'll find it just for you to hear my money. I'm Jim Cramer. All opinions expressed by Jim Cramer on this podcast are solely Cramer's opinions and do not reflect the opinions of CNPC or its parent company or affiliates and may have been previously disseminated by Cramer on television, radio, internet or another medium. You should not treat any opinion expressed by Cramer as a specific inducement to make a particular investment or follow a particular strategy, but only as an expression of his opinion. Cramer's opinions are based upon information he considers reliable, but neither CNBC nor its affiliates and or subsidiaries warrant its completeness or accuracy, and it should not be relied upon as such. To view the full mad money disclaimer, please visit CNBC.com/madmoneydisclaimer.

Podcast Summary

Key Points:

  1. Kramer emphasizes diversifying away from the overhyped data center sector to capture broader investment opportunities.
  2. He highlights strong stories in sectors like aerospace (GE Aerospace’s acquisition), healthcare (Hinge Health, Metronite), energy (Enbridge), and consumer tech (Robinhood, Max Levien’s buy-now-pay-later).
  3. Kramer advocates for strategic portfolio reallocation—selling overexposed data center stocks to avoid market volatility—while recommending high-growth, undervalued, or defensive sectors for better long-term returns.

Summary:

Kramer argues that the market is being overly dominated by data center narratives, leading investors to miss significant opportunities in other sectors. He urges diversification, pointing to strong growth stories such as GE Aerospace’s $12 billion acquisition of a precision castings company, Hinge Health’s rapid expansion in telemedicine, and Enbridge’s resilient pipeline business. He also highlights consumer trends like Robinhood’s young, growing user base and Max Levien’s buy-now-pay-later model.

While acknowledging data centers remain important, Kramer believes overexposure to them is risky. He recommends selling some data center holdings to reduce vulnerability during market downturns and instead allocating capital to resilient, high-growth, or defensive sectors. This approach ensures investors benefit from a broader range of market dynamics.

He also ties this strategy to his fantasy stock football analogy, emphasizing balance, risk management, and diversification—core principles for building a resilient portfolio. Ultimately, Kramer believes the market needs consolidation and more strategic deals, not just data center hype, and calls for disciplined, diversified investing to thrive amid volatility.

FAQs

Kramer highlights opportunities like GE Aerospace's $12 billion acquisition of a casting company, Nvidia and Apple for growth, Enbridge pipelines, and healthcare companies like Hinge Health and Metronite.

He argues that overfocus on data centers and anti-data center backlash can lead to losses, so diversifying into other high-growth areas reduces risk and improves portfolio resilience.

He remains confident in data centers' long-term potential but warns against overexposure, advocating for a balanced portfolio that includes other sectors.

The $12 billion purchase strengthens GE's supply chain for both commercial and defense aircraft, supporting production growth and benefiting Boeing through improved supply chain reliability.

He uses fantasy football to illustrate portfolio diversification, comparing positions like quarterbacks (core stocks), running backs (growth stocks), and defensive players (stable, defensive stocks) to build a balanced portfolio.

He sees SpaceX as a high-risk, high-reward investment with strong long-term potential, especially given its IPO and the unlocking of restricted shares, though it's expensive and speculative.

Chat with AI

Loading...

Pro features

Go deeper with this episode

Unlock creator-grade tools that turn any transcript into show notes and subtitle files.